The EphA8 receptor induces sustained MAP kinase activation to promote neurite outgrowth in neuronal cells

Oncogene

Volumn 24, Issue 26, 2005, Pages 4243-4256

  Gu, Changkyu ^a   Shim, Sungbo ^a,b   Shin, Jongdae ^a,b   Kim, Jieun ^a   Park, Jonghoon ^a   Han, Kyuhyung ^b   Park, Soochul ^a  

^a Sookmyung Women's University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Eph; EphA8; Ephrin; MAP kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; EPHRIN RECEPTOR A8; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; DRUG EFFECT; DRUG MECHANISM; EMBRYO CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FIBROBLAST; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; BRAIN TUMOR; CELL CULTURE; GENETICS; GLIOMA; NEURITE; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN NEOPLASMS; ENZYME ACTIVATION; GLIOMA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NEUROBLASTOMA; NEURONS; PROTEIN-TYROSINE KINASES; RATS; RECEPTOR, EPHA8; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 20544436168     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208584     Document Type: Article

References (28)

1. Becker E, Huynh-Do U, Holland S, Pawson T, Daniel TO and Skolnik EY. (2000). Mol. Cell. Biol., 20, 1537-1545.
2. Choi S, Jeong J, Kim T and Park S. (1999). Mol. Cells, 9, 440-445.
3. Choi S and Park S. (1999). Oncogene, 18, 5413-5422.
4. Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF and Boyd AW. (2002). Int. J. Dev. Biol., 46, 375-384.
5. Elowe S, Holland SJ, Kulkarni S and Pawson T. (2001). Mol. Cell. Biol., 21, 7429-7441.
6. Gendron L, Oligny JF, Payet MD and Gallo-Payet N. (2003). J. Biol. Chem., 278, 3606-3614.
7. Gu C and Park S. (2001). Mol. Cell. Biol., 21, 4579-4597.
8. Gu C and Park S. (2003). FEBS Lett., 540, 65-70.
9. Himanen JP and Nikolov DB. (2003). Int. J. Biochem. Cell Biol., 35, 130-134.
10. Holland SJ, Gale NW, Gish GD, Roth RA, Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD and Pawson T. (1997). EMBO J., 16, 3877-3888.
11. Jeong J, Choi S, Gu C, Lee H and Park S. (2000). DNA Cell Biol., 19, 291-300.
12. Klein R. (2001). Curr. Opin. Cell Biol., 13, 196-203.
13. Koo J, Shim S, Gu C, Yoo O and Park S. (2003). Dev. Dyn., 226, 596-603.
14. Kullander K and Klein R. (2002). Nat. Rev. Mol. Cell Biol., 3, 475-486.
15. Kuo WL, Abe M, Rhee J, Eves EM, McCarthy SA, Yan M, Templeton DJ, McMahon M and Rosner MR. (1996). Mol. Cell. Biol., 16, 1458-1470.
16. Mellitzer G, Xu Q and Wilkinson DG. (2000). Curr. Opin. Neurobiol., 10, 400-408.
17. Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E and Wang B. (2001). Nat. Cell Biol., 3, 527-530.
18. Nelson P, Christian C and Nirenberg M. (1976). Proc. Natl. Acad. Sci. USA, 73, 123-127.
19. Park S, Frisen J and Barbacid M. (1997). EMBO J., 16, 3106-3114.
20. Park S and Sanchez MP. (1997). Oncogene, 14, 533-542.
21. Pratt RL and Kinch MS. (2002). Oncogene, 21, 7690-7699.
22. Schmucker D and Zipursky SL. (2001). Cell, 105, 701-704.
23. Tepass U, Godt D and Winklbauer R. (2002). Curr. Opin. Genet. Dev., 12, 572-582.
24. Tong J, Elowe S, Nash P and Pawson T. (2003). J. Biol. Chem., 278, 6111-6119.
25. Vaudry D, Stork PJ, Lazarovici P and Eiden LE. (2002). Science, 296, 1648-1649.
26. Vindis C, Cerretti DP, Daniel TO and Huynh-Do U. (2003). J. Cell Biol., 162, 661-671.
27. Wilkinson DG. (2001). Nat. Rev. Neurosci., 2, 155-164.
28. Yan M and Templeton DJ. (1994). J. Biol. Chem., 269, 19067-19073.